Showing 3211-3220 of 10618 results for "".
SERENA-6: Assessing Camizestrant’s Impact in HR+/HER2- Breast Cancer
https://reachmd.com/programs/project-oncology/serena-6-assessing-camizestrants-impact-in-hrher2-breast-cancer/36163/The SERENA-6 trial, which was presented at the 2025 ESMO Congress, explores a novel strategy in treating HR+/HER2- advanced breast cancer by switching to camizestrant upon detection of ESR1 mutation prior to disease progression. This approach has been shown to improve progression-free survival and dAdvancing MPE Diagnosis and Prognosis: Clinical Value of Biomarker Integration
https://reachmd.com/programs/clinicians-roundtable/advancing-mpe-diagnosis-and-prognosis-clinical-value-of-biomarker-integration/35660/Cytology via thoracentesis remains the first-line approach for diagnosing malignant pleural effusion (MPE), yet its sensitivity is limited. leaving many patients undiagnosed or delayed in treatment. In this expert-led discussion, Dr. David Feller-Kopman explores the limitations of current diaNavigating Pediatric Obesity: Tools and Strategies for Success in Primary Care
https://reachmd.com/programs/clinicians-roundtable/navigating-pediatric-obesity-tools-and-strategies-for-success-in-primary-care/37868/Discussing weight with pediatric patients and families is a nuanced challenge shaped by stigma, culture, and access—but it’s also a vital opportunity for early intervention. Dr. Jaime Moore shares how to build confidence, counter bias, and leverage practical tools and partnerships that supporBeyond Plaques: Treatment Challenges and Strategies in Palmoplantar Psoriasis
https://reachmd.com/programs/frontlines-psoriasis/beyond-plaques-treatment-challenges-and-strategies-in-palmoplantar-psoriasis/32442/Palmoplantar psoriasis is a high-impact, functionally burdensome condition that often resists conventional therapies. Characterized by painful fissures, thickened plaques, and distinct immune drivers, it requires a treatment approach beyond what's used for classic plaque psoriasis. To learn more, DrUnlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
https://reachmd.com/programs/project-oncology/unlocking-tumor-complexity-single-cell-rna-sequencing-in-lung-cancer/36553/Single-cell RNA sequencing is transforming our understanding of tumor heterogeneity in primary lung cancers by offering insights far beyond traditional bulk sequencing. In this program, Dr. Paola Marignani explores how advanced machine learning enables faster, more precise profiling of genetic diverAdvancing COPD Care: AI-Driven Tools for Enhanced Imaging
https://reachmd.com/programs/frontlines-copd/advancing-copd-care-ai-driven-tools-for-enhanced-imaging/35538/While measurement of functional small airway disease typically requires at least two CT scans, a new generative model shows promise for predicting the disease with just one scan. Dr. Muhammad Chaudhary, instructor of at the University of Alabama at Birmingham School of Medicine, joins us to discussManaging Iatrogenic Colon Perforations: Strategies and Considerations
https://reachmd.com/programs/gi-insights/managing-iatrogenic-colon-perforations-strategies-and-considerations/32747/Colonic perforations during colonoscopy are rare, but when they occur, taking swift and informed action is critical, particularly to avoid surgical intervention. Joining Dr. Peter Buch to offer his insights on perforation prevention, risk-reduction techniques, and repair strategies is Dr. Mark BensoApplying the First 5 Minutes Concept to COPD Care
https://reachmd.com/programs/deep-breaths-updates-chest/applying-the-first-5-minutes-concept-to-copd-care/26814/Tune in to learn how open conversations and the First 5 Minutes concept can improve the care of patients with chronic obstructive pulmonary disease.Balancing Blood Sugar: The Role of Yoga in Diabetes Management
https://reachmd.com/programs/what-your-patients-are-talking-about/tbd/15490/Tune in to find out how yoga can help lower blood sugar levels in patients with type 2 diabetes.Developments in DMD Treatment: The First Nonsteroidal Drug Approval
https://reachmd.com/programs/clinicians-roundtable/developments-in-dmd-treatment-the-first-nonsteroidal-drug-approval/15187/Explore the data that led to the FDA approval of givinostat, the first nonsteroidal treatment option for patients with duchenne muscular dystrophy.